Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
Alberta Stroke Program Early CT score
algorithm
anticoagulant, treatment
baroreceptors
basilar artery occlusion
carotid artery disease
carotid artery disease, medical management
carotid artery occlusion, intracranial
carotid artery stenosis
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, perfusion
cerebral embolism, mechanical extraction
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, etiology
cerebrovascular accident, infancy and childhood
cerebrovascular accident, prognosis in
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time to treatment
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease, risk factors in
clot retrieval
collateral circulation
complications
controversies in neurology
cost
cost effectiveness
coumarin
disability rating scale, neurological
disability, neurological
door to imaging time
door to needle time
door to treatment time
efficacy
endovascular therapy
endovascular therapy, futile interhospital transfer
endovascular therapy, selection criteria
endovascular therapy, time window
ESCAPE trial
EXTEND trial
factor Xa inhibitor
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
intracerebral hemorrhage
ischemic core
MERCI trial
middle cerebral artery, occlusion of
middle cerebral artery, stenosis of
mortality
MR CLEAN
MRI, abnormal
MRI, volumetry
multimodal neuroimaging
neurologic recovery
neuroradiology, interventional
patent foramen ovale
practice guidelines
prognosis
Rankin score
recanalization, arterial
reperfusion
Retriever Device
REVASCAT trials
revascularization, surgical
review article
risk factors
safety
screening
solitaire device
stent, intracranial
SWIFT PRIME Trials
SWIFT trial
T lesion of MCA-ICA
thrombectomy
thrombolysis, mechanical
time is brain
tissue plasminogen activator, intravenous
transport of patient
treatment of neurologic disorder
workup
Showing articles 100 to 150 of 289 << Previous Next >>

Evaluation of Patients for Paroxysmal Atrial Fibrillation after Ischemic Stroke
Stroke 44:e168-e170, Sundararajan, K.,et al, 2013

Pilot Randomized Trial of Outpatient Cardiac Monitoring After Cryptogenic Stroke
Stroke 44:528-530, Kamel, H.,et al, 2013

Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013

Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013

Endovascular Treatment for Acute Ischemic Stroke-Still Unproven
NEJM 368:952-955, Chimowitz,M., 2013

A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
NEJM 368:914-923,952, Kidwell, C.S.,et al, 2013

Stroke Patients with Suspected Atrial Fibrillation Should be Started on Anticoagulation Pending the Results of Long-Term Cardiac Monitoring
Stroke 44:298-299,302, Diener, H., 2013

Stroke Patients with Suspected Atrial Fibrillation Should NOT be Started on Anticoagulation WHILE AWAITING the Results of Long-Term Cardiac Monitoring
Stroke 44:300-301,302, Katsnelson, M. & Sacco, R., 2013

Endovascular Treatment for Acute Ischemic Stroke
NEJM 368:914-923,952, Ciccone, A.,et al, 2013

Retrospective Review of Cerebral Mycotic Aneurysms in 26 Patients: Focus on Treatment in Strongly Immunocompromised Patients with a Brief Literature Review
AJNR 34:823-827, Allen, L.M.,et al, 2013

Occult Atrial Fibrillation in Cryptogenic Stroke
Stroke 44:1449-1452, Ritter, M.,et al, 2013

Incidence of Atrial Fibrillation Detected by Implantable Loop Recorders in Unexplained Stroke
Neurol 80:1546-1550, Corter, P.,et al, 2013

Summary of Evidence-Based Guideline: Periprocedural Management of Antithrombic Medications in Patients with Ischemic Cerebrovascular Disease
Neurol 80:2065-2069, Armstrong, M.,et al, 2013

Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures
NEJM 368:2113-2124, Baron, T.,et al, 2013

Pacemaker of Defibrillator Surgery without Interruption of Anticoagulation
NEJM 368:2084-2093, Birnie, D.,et al, 2013

Insertable Cardiac Event Recorder in Detection of Atrial Fibrillation After Cryptogenic Stroke
Stroke 44:2007-2009, Etgen, T.,et al, 2013

Patent Foramen Ovale and Cryptogenic Stroke
Stroke 44:2676-2678, Furlan, A.J. and Jauss, M., 2013

Trevo Versus Merci Retrievers for Thrombectomy Revascularisation of Large Vessel Occlusions in Acute Ischaemic Stroke (TREVO 2): A Randomised Trial
Lancet 380:1231-1240,1208, Nogueira, R.G.,et al, 2012

Critique of Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Stroke 43:3147-3149, Thaler, D.E.,et al, 2012

Electrophysiological Study with Prophylactic Pacing and Survival in Adults with Myotonic Dystrophy and Conduction System Disease
JAMA 307:1292-1301, Wahbi,K.,et al, 2012

Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012

Stroke Recurrence in Children with Congenital Heart Disease
Ann Neurol 72:103-111, Rodan, L.,et al, 2012

Hemostatic Therapy Should be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2535-2536,2539, Diringer, M. & Zazulia, A.R., 2012

Hemostatic Therapy Should not be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2537-2538,2539, Stapf, C., 2012

Clinicopathologic Conference, Acute Ischemic Stroke due to Basilar Artery Embolism. Patent Foramen Ovale
NEJM 367:1450-1460, Case 31-2012, 2012

Management of Anticoagulation Before and After Elective Surgery
www.uptodate.com Dec. 2012, Lip, G. & Douketis, J., 2012

Mechanical Thrombolysis and Stenting in Acute Ischemic Stroke
Stroke 43:280-285, Gralla, J.,et al, 2012

Subclinical Atrial Fibrillation and the Risk of Stroke
NEJM 366:120-129,178, Healey, J.S., et al, 2012

Self-Monitoring of Oral Anticoagulation: Systematic Review and Meta-Analysis of Individual Patient Data
Lancet 379:322-34, Heneghan,C., 2012

Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
Stroke 43:422-431, Kitsios,G.D.,et al, 2012

Asymmetric Pattern of Cerebrovascular Lesions in Patients after Left Ventricular Assist Device Implantation
Stroke 43:872-874, Kato,T.S.,et al, 2012

Syncope: A Rare Manifestation of a Common Condition
Lancet 379:866, Hogarth,A.,et al, 2012

Therapeutic Devices for Epilepsy
Ann Neurol 71:157-168, Fisher,R.S., 2012

LMNA Cardiomyopathy:Cell Biology and Genetics Meet Clinical Medicine
Disease Models & Mechanisms 4:562-568, Lu,J.T., et al, 2011

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011

Percutaneous Vascular Interventions for Acute Ischemic Stroke
Stroke 42:e31-e32, ORourke,K.,et al, 2011

Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
NEJM 364:2187-98, 2256, Smith, C.R.,et al, 2011

Acute Stroke Therapy at the Crossroads
JAMA 306:2026-2028, Broderick, J.P. and Meyers, P.M., 2011

A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011

Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010

Predictors of Subarachnoid Hemorrhage in Acute Ischemic Stroke With Endovascular Therapy
Stroke 41:2775-2781, Shi,Z.-S.,et al, 2010

Recanalization Devices Should Be Restricted to Clinical Trials: Pro (Kind Of)
Stroke 41:191-193, 196, Schellinger,P. &Hacke,W., 2010

Clot Retrieval for Stroke Should Be Restricted to Clinical Trials: No
Stroke 41:194-195, 196, Furlan,A., 2010

Incidence of Newly Detected Atrial Arrhythmias via Implantable Devices in Patients with a History of Thromboembolic Events
Stroke 41:256-260, Ziegler,P.D.,et al, 2010

Detection of Paroxysmal Atrial Fibrillation with Transtelephonic EKG in TIA or Stroke Patients
Neurol 74:1666-1670, 1662, e94, Gaillard,N., et al, 2010

Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010

Drip, Ship, and Retrieve: Cooperative Recanalization Therapy in Acute Basilar Artery Occlusion
Stroke 41:722-726, Pfefferkorn,T., et al, 2010

Cost-Effectiveness of Outpatient Cardiac Monitoring to Detect Atrial Fibrillation After Ischemic Stroke
Stroke 41:1514-1520, Kamel,H., et al, 2010

Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients
Stroke 41:1996-2000, Abou-Chebl,A.,et al, 2010

Prevalence and Predictors of Paroxysmal Atrial Fibrillation on Holter Monitor in Patients With Stroke or Transient Ischemic Attack
Stroke 41:2596-2600, Alhadramy,O.,et al, 2010



Showing articles 100 to 150 of 289 << Previous Next >>